CNTO surprised by GNE infringment suit

CNTO surprised by GNE infringment suit Centocor Inc. will likely try to negotiate with Genentech Inc. regarding a license for CNTO's CentoRx gpIIb/IIIa platelet inhibitor, rather than see a suit filed by GNE go to trial.

GNE last week said it sued CNTO in the U.S. District Court for Northern California, alleging that CentoRx infringes its U.S. patent No. 4,816,567. The "Cabilly patent," issued in 1989, covers antibody technology related to chimeric immunoglobulin compositions, expression vectors and methods...